A fermentation broth of an unidentified fungus (N983-46) was found to produce DNAgyrase inhibitors, 371 (1) and 372 (2). Following isolation by solvent extraction and silica gel and ODS(reverse phase) chromatographies, the structures were determined to be novel spiro-ketal compounds with S-connguration at position C-l. CJ-12,371 and CJ-12,372 inhibit both DNA supercoiling and relaxation mediated by Escherichia coli DNAgyrase. The interaction of these compounds with DNAgyrase appears to be novel in that the compounds inhibit supercoiling and relaxation without blocking religation; thus, no cleavage intermediate of double strand DNAis observed. Both compounds have antibacterial activity against several species of pathogenic Grampositive bacteria, with MICs between 25 and 100^g/ml. These results suggest that the antibacterial potency of CJ-12,371 and CJ-12,372 is attributed to the inhibition of DNAgyrase. However, the compounds did not inhibit DNAgyrase selectively, as they also inhibited eukaryotic topoisomerase II-mediated relaxation. Semi-synthetic modifications to the dihydroxy motif in CJ-12,371 altered both gyrase-and topoisomerase II-inhibitory activities, but did not enhance selectivity.
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Type II topoisomerases are key enzymes involved in transcription, DNA replication and nucleoid segregation1>2). Procaryotic topoisomerase II (DNAgyrase) is an important target for antibacterial agents as exemplified most recently by the quinolone antibiotics3A); the eukaryotic topoisomerase II is a clinically proven target for anticancer drugs5>6). There are two well-characterized classes of DNAgyrase inhibitors: the quinolone class and the coumarin class. Quinolones are unusual antibiotics in that they are totally synthetic derivatives rather than secondary metabolites; compounds of this structural type interact with the A subunit of DNA gyrase, disrupting the DNAbreakage-reunion reactions of supercoiling3 '4'7) .
The coumarins such as novobiocin and coumermycinAx are microbially derived and interact with the B subunit, inhibiting ATPase activity3'8'9).
Coumarins are not widely used to treat infectious diseases due to the rapid selection of resistance and toxicity; quinolone antibacterial agents are currently used for treatment of skin/soft tissue, respiratory tract, sexually transmitted diseases and urinary tract infections10). However, new classes of DNAgyrase inhibitors are required due to emergence of resistance in important clinical strains11} and the toxicity of quinolone antibacterial agents12). In a screening program designed to discover new DNAgyrase inhibitors from microbial secondary metabolites, a fungal strain N983-46 was found to produce two novel compounds, CJ-12,371 (1) and CJ-12,372 (2) (Fig. 1) . In this paper, we report the fermentation, structural elucidation and biological activities of CJ-12,371 and CJ-12,372.
Producing Organism
The producing strain was provided from MYCO- The fungal strain N983-46 was maintained on potato dextrose agar slant. A vegetative cell suspension from a slant of the fungal strain N983-46 was inoculated into a 500-ml flask (first seed culture) containing 100 ml of seed medium, consisting of 2% glucose, 0.5% Polypepton (Nihon Pharmaceutical Co., Ltd.), 0.5% yeast extract, 0.5% wheat gluten, 0.3% beef extract, 0.3% blood meal and 0.3% CaCO3 (adjusted to pH 7.0 before sterilization). The flask was incubated on a rotary shaker (220 rpm) at 26°C for 4 days. The first seed culture (30 ml)
was transferred to four 500-ml flasks (second seed culture), each containing 150 ml of the seed medium and incubated on a rotary shaker at 26°C for 4days. The second seed culture (600 ml) was transferred to four 6-liter jar fermentors with a small propeller-type impeller (7 cm diameter), each containing 3 liters of production medium, consisting of2% glucose, 3% dextrin, 0.5% Polypepton, 1 % Polypepton-S (Nihon Pharmaceutical Co., Ltd.), 1 % corn steep liquor, 0.3%. NaCl, 0.3% CaCO3 and 0.0001% CoCl2 *6H2O (adjusted to pH 6.5 before sterilization). The fermentation was carried out at 26°C for 3 days with an aeration rate of 3 liters/minute and an agitation rate of 1,700rpm.
Isolation of CJ-12,371 (1) and CJ-12,372 (2) The fermentation broth (15 liters) was freeze-dried, extracted with 70%aqueous acetone (5 liters) and then A part (600mg) of the amorphous substance was subjected to reverse phase chromatography (Kusano Kagakukikai Co., C.I.G. prepacked column C-18) with methanol-water (7: 1), and pure CJ-12,371 (1, 363mg) and CJ-12,372 (2, 196mg) in the 4 fragments deduced from XHNMR.Further, the long range HETCOR experiment was carried out to connect the 4 fragments, all 8 quaternary carbons and phenolic-OH group, yielding partial structures X and Y (Fig. 2) . In this experiment, no correlation was observed between X and Y. However, considering that X and Y contain all chemical elements in the molecular formula, the only way to satisfy the remaining one unsaturation is to connect X and Y through the oxygens to form a 6-memberedspiro-ketal ring as shown in structure 1.
Structural Elucidation of CJ-12,372 (2)
The structure of CJ-12,372 was determined by the similar procedure used to elucidate CJ-12,371 (1). The molecular formula C20H16O5was deduced from HREI-MS (m/z 336.1001, z!0.3mmu) and supported by the number of *H and 13C resonances observed in NMR (Table  2) . When compared to 1, CJ-12,372 has an additional oxygen substituting for one of the aromatic protons, resulting in a phenolic-OH. This conclusion is supported by the appearance of an additional D2O-exchangeable singlet at 8.37ppm and an sp2 singlet at 149.2ppm, with the loss of an sp2 doublet in *H and 13C NMR. The long range HETCOR experiment confirmed the position of the second phenolic-OH and provided the structure (2), with full assignments of XH and 13C signals.
Absolute Stereochemistry at C-l
The absolute stereochemistry at C-l in CJ-12,371 (1) and CJ-12,372 (2) was determined as^-configuration by applying the CD exciton chirality method14) to the O-/?-A^Af-dimethylaminobenzoyl derivatives (3 and 4).
The UVand CDdata are summarized in Table 3 . The CDspectra of 3 and 4 clearly showed a positive first Cotton effect (at 329 and 331nm for 3 and 4, respectively) and a negative second Cotton effect (at 306 and 309nm for 3 and 4, respectively). These strong split Cotton effects are apparently due to the CD exciton coupling between O-p-N,Af-dimethylaminobenzoyl groups at C-l and C-8. This positive exciton chirality indicates that C-l has^-configuration in 3 and 4. The exciton interaction between O-benzoyl groups at C-l and C-5 does not affect the final assignment of the absolute configuration in 4 because the 1 ,5-interaction is relatively weak due to the remote distance compared to 1,8-interaction. The other exciton interactions among benzoates, naphthalene and benzene moieties in 3 and 4 Table 3 . UV and CD data of CJ-12,371 (1), CJ-12,372 (2) and their /?-Af JV-dimethylaminobenzoates (3 and 4). distinguish themselves from the quinolone and coumarin antibiotics in that they inhibit both DNA gyrasemediated supercoiling and relaxation without the formation of a cleavage intermediate (see Fig. 3 for CJ-12,372). This mechanism of action was also seen with atrovenetinones15), another microbially-derived DNA gyrase inhibitors. To determine the selectivity of CJ-12,371 and CJ-12,372, the compounds were tested in a relaxation assay mediated by eukaryotic (Drosophila) topoisomerase II. Both compounds inhibited ATP-dependent relaxation (Table 4 ) and, unlike etoposide (specific topoisomerase II inhibitor), no cleavage intermediate was noted (Fig. 4) . Thus, CJ-12,371 and CJ-12,372 are not specific for DNA gyrase and their mechanism of interaction with either the prokaryotic or eukaryotic enzyme appears to be unique from the classical inhibitors of the respective enzymes.
In an attempt to improve potency and/or enhance selectivity, several semi-synthetic derivatives of CJ-1 2,37 1 were made (Table 5 ). Substitution of one or both of the hydroxyl groups with ethyl, acetyl or methyl groups yielded more potent compounds than CJ-12,371 without improving the selectivity. The best compound, A in Table   5 , was equipotent to CJ-12,372. l ,8-Di-<9-acetyl-CJ-12,371 (0.5 mg), of which preparation will be mentioned later, was treated with K2CO3 (5 mg) in 0.25 ml ofMeOHat 0°C. After 1-hour reaction, the excess MeOHwas evaporated with a flow ofN2. The resulting reaction mixture was filtered through a small silica gel column (1 x 2 cm) with EtOAc to provide 0. CJ-12,371 (1, 0.8mg) was reacted with CH3I (0.1 ml) and K2CO3(5mg) in 0.3ml of tetrahydrofuran at 60°C for 3 hours. After excess CH3I and tetrahydrofuran were evaporated with a flow of N2, the reaction mixture was passed through a small silica gel column (1 x 2cm) with 3ml of CHC13 to elute 8-0-methyl-CJ-12,371 ( added to a final concentration of 0.1 m, the mixture was diluted in half with glycerol, and aliquots were stored at -20°C. One unit ofholoenzyme is defined as the amount of enzyme required to completely supercoil 0.125 /ig of relaxed pBR322 DNA at 30°C in 2hours under the conditions specified below.
DNAGyrase Supercoiling and Relaxation Assays The supercoiling reaction mixture29) (25 jjI) contained 40mM Tris-HCl (pH 7.5), 6.5% glycerol (w/v), 1.4mM ATP (pH 7.0), 0.64mM EDTA, 365 /zg/ml bovine serum albumin, 4mMMgCl2, 24mMKC1, 0.5mM spermidine, 0.05mM dithiothreitol and 0.125 ag relaxed pBR322 Reactions measuring relaxation mediated by DNA gyrase holoenzymewere carried out in the same fashion as the supercoiling reaction, with 4 important exceptions: 1) ATPwas omitted from the reaction mixture, 2) 2 units of holoenzyme were added per reaction, 3) the substrate was supercoiled pBR322 and 4) the stop reagent did not contain SDS.
Eukaryotic Topoisomerase II Relaxation Assay Drosophila topoisomerase II was purchased from United States Biochemicals Corporation. The assay procedure was slightly modified from that suggested by the manufacturer. To start the enzyme reaction, topoisomerase II (1 unit) was added to a mixture (25 jjI) containing 15^1 of sample in 2.4% DMSO, 10mM
Tris-HCl (pH 7.9), 0.45mM Na2HPO4 (pH 7.1), 71 mM NaCl, 50mM KC1, 5mM MgCl2, 7.5% glycerol (w/v), 1.0mM ATP (pH 7.0), 0.08mM dithiothreitol, 0.12mM EDTA, 15 jug/ml BSA and 1.25 fig ofsupercoiled plasmid DNA pBR322 (Nippon Gene Co., Ltd.). The mixture was incubated at 30°C for 30minutes. The enzyme reaction was stopped by adding 2.5fi\ of SDS (2.2%) and 2.5/zl of proteinase K (1.25mg/ml). DNAwas detected by the same procedure described above.
